EA200301323A1 - Однократная вакцинация mycoplasma hyopneumoniae - Google Patents

Однократная вакцинация mycoplasma hyopneumoniae

Info

Publication number
EA200301323A1
EA200301323A1 EA200301323A EA200301323A EA200301323A1 EA 200301323 A1 EA200301323 A1 EA 200301323A1 EA 200301323 A EA200301323 A EA 200301323A EA 200301323 A EA200301323 A EA 200301323A EA 200301323 A1 EA200301323 A1 EA 200301323A1
Authority
EA
Eurasian Patent Office
Prior art keywords
vaccine
hyo
mycoplasma hyopneumoniae
administered
present
Prior art date
Application number
EA200301323A
Other languages
English (en)
Other versions
EA009901B1 (ru
Inventor
Робин Ли Кич
Лайза Грейс Саббадини
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200301323(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200301323A1 publication Critical patent/EA200301323A1/ru
Publication of EA009901B1 publication Critical patent/EA009901B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к способам лечения или предупреждения заболевания или нарушения у животного, вызванного Mycoplasma hyopneumoniae (M. hyo), при котором этому животному в возрасте приблизительно от трех (3) до десяти (10) суток вводят однократную дозу эффективного количества M. hyo вакцины. M. hyo вакцина может представлять собой инактивированный или модифицированный живой препарат на основе целых клеток или их частей, субъединичную вакцину или вакцину на основе нуклеиновых кислот или ДНК. M. hyo вакцина, вводимая в соответствии с настоящим изобретением, может быть синтезирована или получена рекомбинантным путем.Отчет о международном поиске был опубликован 2004.07.29.
EA200301323A 2001-07-02 2002-06-07 Способ лечения или предупреждения заболевания или нарушения у животного, вызванного mycoplasma hyopneumoniae EA009901B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30263601P 2001-07-02 2001-07-02
PCT/IB2002/002121 WO2003003941A2 (en) 2001-07-02 2002-06-07 One dose vaccination with mycoplasma hyopneumoniae

Publications (2)

Publication Number Publication Date
EA200301323A1 true EA200301323A1 (ru) 2005-06-30
EA009901B1 EA009901B1 (ru) 2008-04-28

Family

ID=23168589

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301323A EA009901B1 (ru) 2001-07-02 2002-06-07 Способ лечения или предупреждения заболевания или нарушения у животного, вызванного mycoplasma hyopneumoniae

Country Status (42)

Country Link
US (3) US6846477B2 (ru)
EP (3) EP1474067B2 (ru)
JP (1) JP2005515162A (ru)
KR (1) KR20040030785A (ru)
CN (3) CN1551781B (ru)
AP (1) AP2003002937A0 (ru)
AR (1) AR034678A1 (ru)
AT (1) ATE412426T2 (ru)
AU (1) AU2002309109B2 (ru)
BG (1) BG66481B1 (ru)
BR (1) BR0210804A (ru)
CA (1) CA2451626C (ru)
CY (1) CY1108749T1 (ru)
CZ (1) CZ305781B6 (ru)
DE (1) DE60229666D1 (ru)
DK (3) DK1474067T4 (ru)
DO (1) DOP2002000431A (ru)
EA (1) EA009901B1 (ru)
ES (3) ES2312580T5 (ru)
GT (1) GT200200138A (ru)
HK (4) HK1068250A1 (ru)
HR (1) HRP20031079A2 (ru)
HU (1) HU230246B1 (ru)
IL (1) IL159349A0 (ru)
IS (1) IS7076A (ru)
MA (1) MA27047A1 (ru)
MX (1) MXPA03011599A (ru)
NO (1) NO342654B1 (ru)
NZ (1) NZ530106A (ru)
OA (1) OA12638A (ru)
PA (1) PA8549701A1 (ru)
PE (1) PE20030285A1 (ru)
PL (1) PL209773B1 (ru)
PT (3) PT2027873E (ru)
SK (1) SK288010B6 (ru)
TN (1) TNSN03155A1 (ru)
TW (1) TWI329514B (ru)
UA (1) UA78707C2 (ru)
UY (1) UY27366A1 (ru)
WO (1) WO2003003941A2 (ru)
YU (1) YU102203A (ru)
ZA (1) ZA200309698B (ru)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
EP2371382B1 (en) 2005-12-29 2016-03-02 Boehringer Ingelheim Vetmedica, Inc. Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
EP2275132B1 (en) 2005-12-29 2021-03-03 Boehringer Ingelheim Animal Health USA Inc. Multivalent PCV2 immunogenic compositions and methods of producing them
CN101448521A (zh) * 2006-03-03 2009-06-03 梅瑞尔有限公司 猪肺炎支原体疫苗
WO2008064299A2 (en) * 2006-11-22 2008-05-29 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en) * 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
KR101619730B1 (ko) 2006-12-15 2016-05-12 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 항원을 이용한 돼지의 치료
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
UA98812C2 (ru) * 2007-11-06 2012-06-25 Вайет Ллк Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
KR20100103535A (ko) * 2007-12-31 2010-09-27 베링거잉겔하임베트메디카인코퍼레이티드 외래 아미노산 삽입물을 갖는 ｐｃｖ２ ｏｒｆ２ 바이러스 유사 입자
CN101236206B (zh) * 2008-01-17 2014-10-15 中国兽医药品监察所 一种猪肺炎支原体重组抗原elisa检测试剂盒
KR20100113582A (ko) * 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
ES2569907T3 (es) * 2008-06-27 2016-05-13 Zoetis Services Llc Composiciones adyuvantes novedosas
CA2764424C (en) 2009-06-04 2019-12-31 National Institute Of Advanced Industrial Science And Technology Vaccine for mycoplasma infection
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
WO2011141443A1 (en) 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
CN103140238B (zh) * 2010-07-26 2016-03-16 Qu生物制药公司 免疫原性抗炎组合物
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
DK2609428T3 (en) * 2010-08-27 2016-05-17 Intervet Int Bv STRENGTH TEST FOR VACCINE FORMULATIONS
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
BR112014022067B1 (pt) * 2012-03-07 2022-05-31 Ceva Sante Animale Composição compreendendo antígeno e lipopolissacarídeo
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
MX2015007729A (es) 2012-12-28 2015-09-07 Boehringer Ingelheim Vetmed Composicion inmunogenica que comprende antigenos de mycoplasma.
EP2938747B1 (en) 2012-12-28 2019-05-01 Boehringer Ingelheim Vetmedica GmbH Method of making a mycoplasma vaccine
WO2014121433A1 (zh) * 2013-02-05 2014-08-14 财团法人农业科技研究院 抗霉浆菌的亚单位疫苗
CN104338125A (zh) * 2013-07-29 2015-02-11 普莱柯生物工程股份有限公司 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
CN109675029A (zh) 2013-09-19 2019-04-26 硕腾服务有限责任公司 油基佐剂
MX2016004063A (es) 2013-10-02 2016-06-06 Boehringer Ingelheim Vetmed Variante de la proteina pcv2 orf2 y particulas similares al virus compuestas por esta.
DK3072523T3 (en) * 2013-11-21 2019-04-08 Agricultural Tech Res Inst COMPOSITION FOR PREVENTION AND TREATMENT OF INFECTIONS WITH MYCOPLASMA
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
HUE063288T2 (hu) 2015-01-16 2024-01-28 Zoetis Services Llc Száj és körömfájás betegség vakcina
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
KR101846478B1 (ko) * 2016-08-12 2018-04-06 주식회사 이노백 재조합 단백질을 포함하는 돼지 마이코플라즈마 감염 예방용 백신 조성물
RU2668799C1 (ru) * 2017-09-08 2018-10-02 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) * 2019-07-08 2021-11-12 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) * 2023-12-01 2023-12-29 北京瑞阳瑞泰生物科技有限公司 一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252328A (en) * 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
EP0283840A3 (en) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
DE3881993T2 (de) 1987-09-18 1993-09-30 Akzo Nv Mycoplasma-Impfstoff.
CA2078131A1 (en) 1990-04-02 1991-10-03 Jerry M. Kuner Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
WO1991018627A1 (en) * 1990-05-29 1991-12-12 Smithkline Beecham Corporation Swine pneumonia vaccine and method for the preparation thereof
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (en) 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
ES2225825T3 (es) * 1992-09-28 2005-03-16 Wyeth Holdings Corporation Procedimiento de mejora de las respuestas inmunitarias mediadas por celulas.
US5530874A (en) 1993-02-02 1996-06-25 3Com Corporation Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en) 1993-10-07 1995-04-13 Iowa State University Research Foundation, Inc. Characterization of mycoplasma hyopneumoniae adhesins
PT1820512E (pt) 1994-05-10 2013-10-09 Boehringer Ingelheim Vetmed Vacina viva modificada melhorada contra brsv
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
JP4113588B2 (ja) 1996-09-30 2008-07-09 ユニヴァーシティ・オヴ・アーカンサス ワクチン結合物を用いて免疫活性を産生する方法
EP0846468B1 (en) 1996-12-05 2004-06-09 Akzo Nobel N.V. Non-virulent mycoplasma synoviae and vaccine thereof
HUP0100130A2 (hu) 1997-11-26 2001-05-28 Iowa State University Research Foundation, Inc. Rekombináns Mycoplasma hyopneumoniae vakcina
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

Also Published As

Publication number Publication date
UY27366A1 (es) 2003-04-30
IL159349A0 (en) 2004-06-01
ES2312580T5 (es) 2017-12-11
BR0210804A (pt) 2005-05-03
ES2312580T3 (es) 2009-03-01
MA27047A1 (fr) 2004-12-20
EP2027873B8 (en) 2015-11-11
UA78707C2 (en) 2007-04-25
PL373367A1 (en) 2005-08-22
DK2027873T3 (en) 2015-11-09
BG108546A (bg) 2005-02-28
IS7076A (is) 2003-12-15
DOP2002000431A (es) 2003-01-15
CN102872456A (zh) 2013-01-16
HUP0400434A2 (en) 2007-08-28
CN1551781B (zh) 2013-01-02
EP1474067A2 (en) 2004-11-10
NO342654B1 (no) 2018-06-25
EP2027873A1 (en) 2009-02-25
CA2451626C (en) 2011-05-31
AP2003002937A0 (en) 2003-12-31
HU230246B1 (hu) 2015-11-30
OA12638A (en) 2006-06-15
US6846477B2 (en) 2005-01-25
CZ305781B6 (cs) 2016-03-16
NO20035762L (no) 2004-02-02
PL209773B1 (pl) 2011-10-31
CN1551781A (zh) 2004-12-01
HK1180224A1 (zh) 2013-10-18
ES2550458T3 (es) 2015-11-10
KR20040030785A (ko) 2004-04-09
ZA200309698B (en) 2014-04-30
CA2451626A1 (en) 2003-01-16
SK288010B6 (sk) 2012-10-02
AU2002309109B2 (en) 2007-12-13
WO2003003941A2 (en) 2003-01-16
BG66481B1 (bg) 2015-02-27
PE20030285A1 (es) 2003-03-27
AR034678A1 (es) 2004-03-03
EP2842569A1 (en) 2015-03-04
PT2027873E (pt) 2015-11-03
ATE412426T2 (de) 2008-11-15
CN101524532A (zh) 2009-09-09
DK1474067T3 (da) 2008-12-08
DK2842569T3 (da) 2019-05-20
GT200200138A (es) 2003-05-15
PA8549701A1 (es) 2003-01-24
HK1207584A1 (en) 2016-02-05
EP1474067A4 (en) 2005-08-10
ES2729579T3 (es) 2019-11-04
EP2842569B1 (en) 2019-04-10
NZ530106A (en) 2007-06-29
CY1108749T1 (el) 2014-04-09
DE60229666D1 (de) 2008-12-11
MXPA03011599A (es) 2005-03-07
SK15792003A3 (sk) 2005-09-08
PT2842569T (pt) 2019-06-17
CN101524532B (zh) 2014-03-19
USRE44399E1 (en) 2013-07-30
PT1474067E (pt) 2008-11-14
WO2003003941A3 (en) 2004-07-29
TWI329514B (en) 2010-09-01
HK1134900A1 (en) 2010-05-20
HK1068250A1 (en) 2005-04-29
EP1474067B2 (en) 2017-08-16
CN102872456B (zh) 2016-01-20
YU102203A (sh) 2006-05-25
EA009901B1 (ru) 2008-04-28
US20030109473A1 (en) 2003-06-12
TNSN03155A1 (fr) 2005-12-23
DK1474067T4 (en) 2017-10-16
JP2005515162A (ja) 2005-05-26
EP1474067B1 (en) 2008-10-29
EP2027873B1 (en) 2015-09-09
HRP20031079A2 (en) 2005-10-31
US20050013823A1 (en) 2005-01-20
CZ20033466A3 (cs) 2005-06-15

Similar Documents

Publication Publication Date Title
EA200301323A1 (ru) Однократная вакцинация mycoplasma hyopneumoniae
EA200301324A1 (ru) Вакцина mycoplasma bovis и способы сокращения пневмонии у животных
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
BRPI0614119B8 (pt) vacina para imunizar gatos contra calicivírus de felino
RU2010149495A (ru) Новые адъювантные композиции
DK1185660T3 (da) Svinecircovirus-vaccine i rekombinant poxvirus
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
NO20011586D0 (no) Nye metoder for terapeutisk vaksinasjon
BR0111366A (pt) Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
RU2010120324A (ru) Вакцина против вируса синего языка и иммуногенные композиции, способы их применения и способы их получения
DE69635472D1 (de) Impfstoff gegen Geflügelkokzidose
BR0107767A (pt) Vacinas dna melhoradas para animais de renda
CY1116862T1 (el) Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae
BR0112486A (pt) Poliproteìna, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição farmacêutica, e, método para imunizar um indivìduo contra hiv
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo
BRPI0413290A (pt) composto para a vacinação de um animal, molécula de ácido nucleico, vetor de expressão, célula hospedeira, vacina, composição farmacêutica, métodos para imunizar um animal contra uma doença, e para combater uma doença em um animal, doença em animal, uso de um composto e um ácido nucleico, e para determinar se a um animal foi administrado com um composto, kit de partes, e, método para vacinar um animal
RU2617043C1 (ru) Вакцина против ящура и способ её получения и применения
El-Bagoury et al. Evaluation of inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 201 VG
Garg et al. Vaccines and Other Biologicals
ES2172482B1 (es) Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania".
Buonavoglia et al. Duration of Immunity in Swine Inoculated with a Monovalent Foot‐and‐Mouth Disease Oil Emulsion Vaccine
ATE373675T1 (de) Impfstoff gegen pferdearteritisvirus
TH64472A (th) การให้วัคซีนขนาดยาเดียวที่มี Mycoplasma Hyopneumoniae
BR0012589A (pt) Proteìna recombinante, composição farmacêutica, composição de vacina, molécula de ácido nucleico, vetor, célula hospedeira, animal transgênico, uso de uma proteìna recombinante, processo para a formulação de uma composição farmacêutica, e, métodos para a prevenção ou tratamento de uma doença em um indivìduo, para preparar uma proteìna recombinante, e para vacinar um mamìfero contra uma doença ou de tratar um mamìfero sofrendo de uma doença

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
TC4A Change in name of a patent proprietor in a eurasian patent
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title